Bridging the Gap: Nanosensors’ Role in Tracking Biomarkers for Health Monitoring
DOI:
https://doi.org/10.47611/jsrhs.v14i1.8853Keywords:
Biomarkers, Nanosensors, Alzheimer’s Disease, Treatments, HealthcareAbstract
Nanosensors, a miniscule sensing device, are used for many things that can be helpful to human life. For one, they can help detect the presence of biomarkers, and are used to correctly identify the presence of a disease, infection, or environmental exposure to contagions. This has been proven helpful as they can detect these diseases or infections at very low concentrations. They can also be extremely specific and eliminate false positives, and can be very cost efficient. However, there seems to be a research gap as biomarkers can actually change a lot over time in certain diseases like cancer. Because of these changes, the results of certain biomarker tests may not be as accurate and efficient in terms of treatments. Many consequences of this include delayed or wrong treatments, psychological stress, and can even result in a lot of medical debt. This can provide negative after effects, especially if one lives in a country with poor healthcare. The problem here is that biomarker tests may not be accurate in terms of detecting biomarkers in the body, due to the ability of biomarkers to change drastically. To further investigate the different types of nanosensors, the methodology will include six experimental groups selected from multiple countries, correlating with six diseases, and one control group. Every three months over the course of two years, the experimental groups will receive the nanosensors that will detect their biomarkers change over time, and the control group will be receiving regular biomarker tests. The results will be used to develop more effective personalized treatment.
Downloads
References or Bibliography
Anic, G. M., Rostron, B. L., Hammad, H. T., van Bemmel, D. M., Del Valle-Pinero, A. Y., Christensen, C. H., Erives, G., Faulcon, L. M., Blount, B. C., Wang, Y., Wang, L., Bhandari, D., Calafat, A. M., Kimmel, H. L., Everard, C. D., Compton, W. M., Edwards, K. C., Goniewicz, M. L., Wei, B., & Hyland, A. (2022). Changes in Biomarkers of Tobacco Exposure among Cigarette Smokers Transitioning to ENDS Use: The Population Assessment of Tobacco and Health Study, 2013–2015. International Journal of Environmental Research and Public Health, 19(3), 1462. https://doi.org/10.3390/ijerph19031462
Bensalah, K., Montorsi, F., & Shariat, S. F. (2007). Challenges of cancer biomarker profiling. European Urology, 52(6), 1601–1609. https://doi.org/10.1016/j.eururo.2007.09.036
Bodaghi, A., Fattahi, N., & Ramazani, A. (2023). Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases. Heliyon, 9(2), e13323. https://doi.org/10.1016/j.heliyon.2023.e13323
Borrebaeck, C. A. K. (2017). Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer. Nature Reviews Cancer, 17(3), 199–204. https://doi.org/10.1038/nrc.2016.153
Chelliah, R., Wei, S., Daliri, E. B.-M., Rubab, M., Elahi, F., Yeon, S.-J., Jo, K. hee, Yan, P., Liu, S., & Oh, D. H. (2021). Development of Nanosensors Based Intelligent Packaging Systems: Food Quality and Medicine. Nanomaterials, 11(6), 1515. https://doi.org/10.3390/nano11061515
Collins, S., Roy, S., & Masitha, R. (2023, October 26). Paying for It: How Health Care Costs and Medical Debt Are Making Americans Sicker and Poorer. Www.commonwealthfund.org. https://www.commonwealthfund.org/publications/surveys/2023/oct/paying-for-it-costs-debt-americans-sicker-poorer-2023-affordability-survey
Comite, F., Santostasi, G., Sansaricq, G., & Fisch, M. (2019). SAT-LB024 Imprecision in Biomarker Analysis: Major Hurdle to Detection and Reversal of Disorders of Aging? Journal of the Endocrine Society, 3(Supplement_1). https://doi.org/10.1210/js.2019-sat-lb024
Engel, J., Pitkänen, A., Loeb, J. A., Edward Dudek, F., Bertram, E. H., Cole, A. J., Moshé, S. L., Wiebe, S., Jensen, F. E., Mody, I., Nehlig, A., & Vezzani, A. (2013). Epilepsy biomarkers. Epilepsia, 54, 61–69. https://doi.org/10.1111/epi.12299
Facts about Depression | Hope for Depression. (2013). Hope for Depression. https://www.hopefordepression.org/depression-facts/
Gratas, S. (2023, January 17). Nearly every Georgia county faces a shortage of primary care providers. Georgia Public Broadcasting. https://www.gpb.org/news/2023/01/17/nearly-every-georgia-county-faces-shortage-of-primary-care-providers
Hampel, H., O’Bryant, S. E., Molinuevo, J. L., Zetterberg, H., Masters, C. L., Lista, S., Kiddle, S. J., Batrla, R., & Blennow, K. (2018). Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nature Reviews Neurology, 14(11), 639–652. https://doi.org/10.1038/s41582-018-0079-7
Hayes, A. (2022, July 20). T-Test: What It Is With Multiple Formulas and When To Use Them. Investopedia. https://www.investopedia.com/terms/t/t-test.asp
Health Care Costs by Country 2020. (2023). Worldpopulationreview.com. https://worldpopulationreview.com/country-rankings/health-care-costs-by-country
Health in Georgia: Statistics, rankings, and data trends on deaths, spending, life expectancy, and more. (2023, August 7). USAFacts. https://usafacts.org/topics/health/state/georgia/
Introduction to lab-on-a-chip 2020: review, history and future. (2023). Elveflow. https://www.elveflow.com/microfluidic-reviews/general-microfluidics/introduction-to-lab-on-a-chip-review-history-and-future/
Janes, H., Pepe, M. S., McShane, L. M., Sargent, D. J., & Heagerty, P. J. (2015). The Fundamental Difficulty With Evaluating the Accuracy of Biomarkers for Guiding Treatment. Journal of the National Cancer Institute, 107(8), djv157. https://doi.org/10.1093/jnci/djv157
Jin, G., Han, Y., Liu, C., Chen, L., Ding, B., Xuan, S., Liu, X., Ma, G., Gao, J., & Tian, X. (2015). Evaluation of biomarker changes after administration of various neoadjuvant chemotherapies in breast cancer. International Journal of Clinical and Experimental Pathology, 8(1), 914–921. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348938/
Leygo, C., Williams, M., Jin, H. C., Chan, M. W. Y., Chu, W. K., Grusch, M., & Cheng, Y. Y. (2017). DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer. Disease Markers, 2017, 1–13. https://doi.org/10.1155/2017/3726595
Luangdilok, S., Samarnthai, N., & Korphaisarn, K. (2014). Association between Pathological Complete Response and Outcome Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients. Journal of Breast Cancer, 17(4), 376. https://doi.org/10.4048/jbc.2014.17.4.376
Masterson, L., & Megna, M. (2023). The Worst (And Best) States For Healthcare, Ranked – Forbes Advisor. Www.forbes.com. https://www.forbes.com/advisor/health-insurance/best-worst-states-for-healthcare/
MD, D. L. T. (2023, August 10). Study detects biomarker changes nearly 30 years before symptom onset of Alzheimer’s disease. News-Medical. https://www.news-medical.net/news/20230810/Study-detects-biomarker-changes-nearly-30-years-before-symptom-onset-of-Alzheimere28099s-disease.aspx
Mishra, A., & Verma, M. (2010). Cancer Biomarkers: Are We Ready for the Prime Time? Cancers, 2(1), 190–208. https://doi.org/10.3390/cancers2010190
Rajan, K. B., McAninch, E. A., Aggarwal, N. T., Barnes, L. L., Wilson, R. S., Weuve, J., DeCarli, C., & Evans, D. A. (2022). Longitudinal Changes in Blood Biomarkers of Clinical Alzheimer Disease in a Biracial Population Sample. 100(8), e874–e883. https://doi.org/10.1212/wnl.0000000000201289
Shvili, J. (2020, May 30). 10 Countries Without Universal Healthcare. WorldAtlas. https://www.worldatlas.com/articles/10-notable-countries-that-are-still-without-universal-healthcare.html
Tolles, J., Bai, Y., Baquero, M., Harris, L. N., Rimm, D. L., & Molinaro, A. M. (2011). Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma. Breast Cancer Research, 13(3). https://doi.org/10.1186/bcr2882
Published
How to Cite
Issue
Section
Copyright (c) 2025 Manasa Shankar; Dr. Kristina Lilova, Virgel Torremocha, Jothsna Kethar
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
